ABSCI
Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creationâ„¢ Platform to identify novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. Biotech and pharma innovators partner with us to create the next generation of protein-based drugs, including Bionic Proteinsâ„¢ containing nonstandard amino acids, and other novel drug designs that may be impossible to make with other technologies. Our goal is to enable the development of better medicines by Translating Ideas into Drugsâ„¢. For more information visit www.absci.com.
ABSCI
Industry:
Artificial Intelligence Biopharma Biotechnology Life Science
Founded:
2011-01-01
Address:
Vancouver, Washington, United States
Country:
United States
Website Url:
http://www.absci.com
Total Employee:
101+
Status:
Active
Contact:
360-949-1041
Total Funding:
237.86 M USD
Technology used in webpage:
IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Google Apps For Business GoDaddy DNS GoDaddy Google Web Toolkit
Similar Organizations
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Principia Biopharma
Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
2020-10-01
Current Employees Featured
Deniz Kural SVP Target & Antibody Discovery @ Absci
SVP Target & Antibody Discovery
2021-06-01
Denise Dettore Chief People Officer @ Absci
Chief People Officer
2022-07-01
Jack Gold Chief Marketing Officer @ Absci
Chief Marketing Officer
Sean McClain Founder, Director & CEO @ Absci
Founder, Director & CEO
2011-08-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-06-14 | Totient | Totient acquired by Absci | N/A |
| 2021-01-12 | Denovium | Denovium acquired by Absci | N/A |
Investors List
Perceptive Advisors
Perceptive Advisors investment in Venture Round - Absci
D1 Capital Partners
D1 Capital Partners investment in Venture Round - Absci
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Venture Round - Absci
aMoon Fund
aMoon Fund investment in Venture Round - Absci
Irving Investors
Irving Investors investment in Venture Round - Absci
Helicase Venture
Helicase Venture investment in Venture Round - Absci
ArrowMark Partners
ArrowMark Partners investment in Venture Round - Absci
Redmile Group
Redmile Group investment in Venture Round - Absci
Casdin Capital
Casdin Capital investment in Venture Round - Absci
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Corporate Round - Absci
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-14 | Absci Prepares for Next Stage of Growth with Executive Human Resources and Marketing Hires |
Official Site Inspections
http://www.absci.com Semrush global rank: 4.28 M Semrush visits lastest month: 2.71 K
- Host name: 104.26.6.50
- IP address: 104.26.6.50
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Absci"
Absci - Crunchbase Company Profile & Funding
Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. We built our …See details»
Investor Relations | Absci Corp
Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to …See details»
About Us - Absci
Leveraging our synthetic biology roots, Absci has built a proprietary data advantage that fuels a continuous learning cycle: data to train, AI to create, and wet lab to validate in as little as six …See details»
Team - Absci
Dr. Taylor-Weiner leads Absci's AI teams and technology, developing Absci's first-in-class ability to design and validate de novo therapeutic antibodies with zero-shot generative AI. He brings …See details»
Events and presentations - Absci Corp
Mar 19, 2025 Absci Q4 and Full Year 2024 Business Update and Financial and Operating Results Conference Call . 03/18/2025 at 4:30 PM EDT Click here for webcast. TD Cowen 45th …See details»
Board of directors - Absci Corp
The Investor Relations website contains information about Absci Corp's business for stockholders, potential investors, and financial analysts.See details»
Absci Corporation (ABSI) - Yahoo Finance Canada
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies …See details»
Absci - Funding, Financials, Valuation & Investors - Crunchbase
Absci has a post-money valuation in the range of $500M to $1B as of Mar 23, 2021, according to PrivCo. Sign up for a free trial to view exact valuation and search companies with similar …See details»
Absci Reports Business Updates and Fourth Quarter and Full
Mar 18, 2025 Absci will host a conference call to discuss its fourth quarter and full year 2024 business updates and financial and operating results on Tuesday, March 18, 2025 at 4:30 p.m. …See details»
Absci 2025 Company Profile: Stock Performance
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and …See details»
Absci Company Profile - Office Locations, Competitors, Revenue
Oct 29, 2024 Absci has 1 employees across 4 locations and $5.72 m in annual revenue in FY 2023. See insights on Absci including office locations, competitors, revenue, financials, …See details»
Absci Headquarters & Office Locations | Clay
Absci's headquarters is situated at 18105 SE Mill Plain Blvd, Vancouver, United States. This location serves as the main office for the company, housing key departments and leadership …See details»
Absci Becomes a Publicly Traded Company | Absci
Jul 22, 2021 Sean McClain celebrates today’s milestone moment as Absci becomes a publicly traded company. Ten years ago, with a vision to revolutionize the way protein-based drugs are …See details»
Absci Reports Business Updates and Fourth Quarter and Full Year …
Mar 18, 2025 Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated …See details»
Working At AbSci: Company Overview and Culture - Zippia
Mar 14, 2024 Learn about working at AbSci from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more. ... Organization Type. Public. …See details»
Absci Reports Business Updates and Third Quarter 2024 Financial …
Nov 12, 2024 This amount includes the expected costs associated with advancing the IND-enabling studies for ABS-101 with a third-party contract research organization. Absci …See details»
Contact us - Absci
Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins.See details»
Absci Reports Business Updates and Fourth Quarter and Full
Mar 18, 2025 --Absci Corporation, a data-first generative AI drug creation company, today reported financial and operating results for the quarter and full year ended December 31, …See details»
AbSci Develops Game-Changing 12-Week Cell Line Optimization …
Apr 5, 2019 Martina Molsbergen, AbSci's new Vice President of Business Development, brings more than 25 years of licensing and senior management leadership experience to the AbSci …See details»
Expanding our Horizons from Coast to Coast | Absci
Apr 21, 2022 When I founded Absci ten years ago in a tiny basement lab, I could never have imagined the incredible journey that brought us to our current, purpose-built headquarters in …See details»